This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: The Innovations of Peter Nelboeck-Hochstetter
Introduction
Peter Nelboeck-Hochstetter is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biomedical research, particularly in the study of amyloidopathies, including Alzheimer's disease. His work has led to the development of innovative animal models that aid in understanding complex neurological conditions.
Latest Patents
One of Peter Nelboeck-Hochstetter's key patents is titled "Double transgenic mice overexpressing human beta secretase and human APP-London." This invention relates to a novel animal model for amyloidopathies, especially Alzheimer's disease, which overexpresses human BACE and human APP London. The model exhibits several aspects of amyloidopathy, providing a valuable tool for researchers. The patent also includes methods for producing these double transgenic animals, as well as cells and cell lines derived from them. Furthermore, it outlines a method for evaluating the in vivo effects of beta-secretase activity on A-beta peptide generation, amyloidosis, neurodegeneration, and Alzheimer's disease pathology in these animals.
Career Highlights
Peter Nelboeck-Hochstetter is associated with Hoffmann-La Roche Inc., a leading global healthcare company. His work at the company has been instrumental in advancing research in neurodegenerative diseases. With a focus on innovative solutions, he continues to contribute to the scientific community.
Collaborations
Throughout his career, Peter has collaborated with esteemed colleagues, including Laurence Mosbach-Ozmen and Helmut Jacobsen. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in the field.
Conclusion
Peter Nelboeck-Hochstetter's contributions to the field of biomedical research, particularly through his innovative patent on double transgenic mice, highlight his commitment to advancing our understanding of Alzheimer's disease. His work continues to inspire future research and innovation in the fight against neurodegenerative disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile